Hypoglycemic Drugs Market CAGR of 9.2% Size, Share, Growth & Forcasts to 2024-2031 | Eli Lilly & Company, Merck & Co.
Global hypoglycemic drugs market is estimated to be valued at US$ 660 Mn in 2022 and expected to exhibit a CAGR of 9.2% during the forecast period (2022-2030) BURLINGAME, CA, UNITED STATES, December 11, 2024 /EINPresswire.com/ -- The research report on …